Literature DB >> 23904472

Individualised exercise improves endothelial function in patients with rheumatoid arthritis.

George S Metsios1, Antonios Stavropoulos-Kalinoglou, Jet J C S Veldhuijzen van Zanten, Peter Nightingale, Aamer Sandoo, Theodoros Dimitroulas, George D Kitas, Yiannis Koutedakis.   

Abstract

BACKGROUND: We investigated the effects of individualised combined resistance and aerobic exercise on microvascular and macrovascular function in rheumatoid arthritis (RA) patients.
METHODS: Forty age-matched, gender-matched and body mass index (BMI)-matched patients were allocated to either an exercise group, receiving a 6 months tailored aerobic and resistance exercise intervention, or controls receiving only information about the benefits of exercise. Participants were assessed for microvascular (acetylcholine (Ach) and sodium nitroprusside (SNP)) and macrovascular (flow-mediated dilatation (FMD) and glyceryl trinitrate (GTN)) endothelial function, maximal oxygen uptake, disease activity and severity (C-reactive protein (CRP), disease activity score 28 and health assessment questionnaire). Data were collected at baseline, 3 months and at the end of the intervention (6 months).
RESULTS: At baseline, demographic, anthropometric, disease-related characteristics and endothelial function parameters were similar between the exercise and control groups (p>0.05). Repeated measures analysis of variance revealed a significant improvement in endothelial function parameters at 3 (GTN: p<0.001) or 6 months (Ach: p=0.016, SNP: p=0.045, FMD: p=0.016) in the exercise but not in the control group. Generalised estimated equations detected that maximal oxygen uptake was a strong predictor for the observed changes in Ach (p=0.009) and GTN (p<0.001) whereas logCRP for SNP (p=0.017) and GTN (p=0.008).
CONCLUSIONS: An exercise programme designed to meet individual needs and physical abilities significantly improves microvascular and macrovascular function in parallel with disease-related characteristics in RA patients. The potential long-term beneficial effects of such interventions at reducing cardiovascular risk in these patients merit further exploration. CLINICAL TRIAL REGISTRATION: ISRCTN50861407.

Entities:  

Keywords:  Cardiovascular Disease; Inflammation; Rehabilitation; Rheumatoid Arthritis

Mesh:

Year:  2013        PMID: 23904472     DOI: 10.1136/annrheumdis-2013-203291

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  40 in total

1.  Preventing Heart Failure in Inflammatory and Immune Disorders.

Authors:  Maya Serhal; Chris T Longenecker
Journal:  Curr Cardiovasc Risk Rep       Date:  2014-06

2.  Association of Light-Intensity Physical Activity With Lower Cardiovascular Disease Risk Burden in Rheumatoid Arthritis.

Authors:  Samannaaz S Khoja; Gustavo J Almeida; Mary Chester Wasko; Lauren Terhorst; Sara R Piva
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-04       Impact factor: 4.794

Review 3.  Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis.

Authors:  Silvio Romano; Elisa Salustri; Piero Ruscitti; Francesco Carubbi; Maria Penco; Roberto Giacomelli
Journal:  Curr Rheumatol Rep       Date:  2018-11-05       Impact factor: 4.592

4.  Factors associated with disability among middle-aged and older African American women with osteoarthritis.

Authors:  Janiece L Walker; Tracie C Harrison; Adama Brown; Roland J Thorpe; Sarah L Szanton
Journal:  Disabil Health J       Date:  2016-03-09       Impact factor: 2.554

5.  Comparison of the effects of exercise and anti-TNF treatment on cardiovascular health in rheumatoid arthritis: results from two controlled trials.

Authors:  Jet J C S Veldhuijzen van Zanten; Aamer Sandoo; George S Metsios; Antonios Stavropoulos-Kalinoglou; Nikos Ntoumanis; George D Kitas
Journal:  Rheumatol Int       Date:  2018-11-12       Impact factor: 2.631

6.  Physical activity and the association with fatigue and sleep in Danish patients with rheumatoid arthritis.

Authors:  K Løppenthin; B A Esbensen; M Østergaard; P Jennum; A Tolver; M Aadahl; T Thomsen; J Midtgaard
Journal:  Rheumatol Int       Date:  2015-05-07       Impact factor: 2.631

Review 7.  Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications.

Authors:  Bryant R England; Geoffrey M Thiele; Daniel R Anderson; Ted R Mikuls
Journal:  BMJ       Date:  2018-04-23

8.  Three months of moderate-intensity exercise reduced plasma 3-nitrotyrosine in rheumatoid arthritis patients.

Authors:  Alex J Wadley; Jet J C S Veldhuijzen van Zanten; Antonios Stavropoulos-Kalinoglou; George S Metsios; Jacqueline P Smith; George D Kitas; Sarah Aldred
Journal:  Eur J Appl Physiol       Date:  2014-04-10       Impact factor: 3.078

Review 9.  The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis.

Authors:  George S Metsios; R H Moe; M van der Esch; J J C S Veldhuijzen van Zanten; S A M Fenton; Y Koutedakis; P Vitalis; N Kennedy; N Brodin; C Bostrom; T W Swinnen; K Tzika; K Niedermann; E Nikiphorou; G E Fragoulis; T P V M Vlieland; C H M Van den Ende; George D Kitas
Journal:  Rheumatol Int       Date:  2019-12-04       Impact factor: 2.631

Review 10.  Cardiovascular comorbidity in rheumatic diseases.

Authors:  Michael T Nurmohamed; Maaike Heslinga; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2015-08-18       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.